Heartland Payment (HPY) was upgraded at Stifel Nicolaus to hold from sell. Stock is attractive, following a sharp selloff, Stifel Nicolaus said.

Heartware (HTWR) was upgraded at BTIG to buy. Twelve-month price target is $100. Stock is down 20% from its highs, BTIG said.

Johnson & Johnson (JNJ) was downgraded at Jefferies to hold from buy. Though company still has strong fundamentals, the valuation is too high, Jefferies said. Twelve-month price target is $105.

Eli Lilly (LLY) was upgraded at Jefferies to hold from underperform. Material downside catalysts are removed, Jefferies said. Twelve-month price target is $54.

MasterCard (MA) was upgraded at Robert Baird to outperform from neutral. Twelve-month price target is $83. Company has strong secular tailwinds and generates solid cash flow, Robert Baird said.

Medtronic (MDT) was downgraded at J.P. Morgan to neutral from overweight. Twelve-month price target is $64. CoreValve injunction adds significant risk to the model, J.P. Morgan said.

Microsoft (MSFT) was downgraded at Deutsche Bank to hold. Twelve-month price target is $42. Company lacks near-term catalysts, Deutsche Bank said.

Palo Alto Networks (PANW) was upgraded at Barclays to overweight from equal-weight. Driven by improvement in market trends, recent pullback and overhang from litigation with Juniper is in the past, Barclays said. Twelve-month price target is $78.

Transocean (RIG) was upgraded at Deutsche Bank to hold from sell. Valuation call, as the sector has underperformed for so long, Deutsche Bank said.

Seagate (STX) was upgraded at Argus to buy from hold. Stock has pulled back, but growth prospects are improving, Argus said.

Sempra Energy (SRE) was initiated at UBS with a buy rating. Company is involved with various levels of energy infrastructure with bulk of its growth tied to LNG exports, UBS said. Underlying core utility business in CA is also well-positioned, UBS said. Twelve-month price target is $106.

Visa (V) was upgraded at Robert Baird to outperform from neutral. Twelve-month price target is $245. Risk/reward has become more attractive at current levels, Baird said.

If you liked this article you might like

Crazy Weak U.S. Dollar Will Make These 10 Companies Huge Winners

Cramer: Goldman's Downgrade Of J&J Is 'Questionable'

Johnson & Johnson Stock Sinks, Goldman Downgrades to 'Sell'

The Best Companies for Women

Ridiculously Weak U.S. Dollar Will Make These 10 Companies Huge Winners